These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11323304)

  • 21. Cutting edge: a new tool to evaluate human pre-erythrocytic malaria vaccines: rodent parasites bearing a hybrid Plasmodium falciparum circumsporozoite protein.
    Persson C; Oliveira GA; Sultan AA; Bhanot P; Nussenzweig V; Nardin E
    J Immunol; 2002 Dec; 169(12):6681-5. PubMed ID: 12471098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic vaccine update: applying lessons learned from recent SPf66 malarial vaccine physicochemical, structural and immunological characterization.
    Bermúdez A; Reyes C; Guzmán F; Vanegas M; Rosas J; Amador R; Rodríguez R; Patarroyo MA; Patarroyo ME
    Vaccine; 2007 May; 25(22):4487-501. PubMed ID: 17403557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles.
    Doolan DL; Southwood S; Chesnut R; Appella E; Gomez E; Richards A; Higashimoto YI; Maewal A; Sidney J; Gramzinski RA; Mason C; Koech D; Hoffman SL; Sette A
    J Immunol; 2000 Jul; 165(2):1123-37. PubMed ID: 10878392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines.
    Espinosa DA; Vega-Rodriguez J; Flores-Garcia Y; Noe AR; Muñoz C; Coleman R; Bruck T; Haney K; Stevens A; Retallack D; Allen J; Vedvick TS; Fox CB; Reed SG; Howard RF; Salman AM; Janse CJ; Khan SM; Zavala F; Gutierrez GM
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody responses to Plasmodium falciparum sporozoite-, liver- and blood-stage synthetic peptides in migrant and autochthonous populations in malaria endemic areas.
    Ferreira-da-Cruz MF; Deslandes DC; Oliveira-Ferreira J; Montenegro-James S; Tartar A; Druilhe P; Daniel-Ribeiro CT
    Parasite; 1995 Mar; 2(1):23-9. PubMed ID: 9137641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens.
    Trieu A; Kayala MA; Burk C; Molina DM; Freilich DA; Richie TL; Baldi P; Felgner PL; Doolan DL
    Mol Cell Proteomics; 2011 Sep; 10(9):M111.007948. PubMed ID: 21628511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential antibody recognition of four allelic variants of the merozoite surface protein-2 (MSP-2) of Plasmodium falciparum.
    Tonhosolo R; Wunderlich G; Ferreira MU
    J Eukaryot Microbiol; 2001; 48(5):556-64. PubMed ID: 11596920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rice-produced MSP142 of Plasmodium falciparum elicits antibodies that inhibit parasite growth in vitro.
    Chen Q; Liang W; Qian F; Qian B; Cao J; Zhang D; Xu Y; Tang L
    Parasite Immunol; 2016 Oct; 38(10):635-41. PubMed ID: 27493141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood Stage Malaria Disrupts Humoral Immunity to the Pre-erythrocytic Stage Circumsporozoite Protein.
    Keitany GJ; Kim KS; Krishnamurty AT; Hondowicz BD; Hahn WO; Dambrauskas N; Sather DN; Vaughan AM; Kappe SHI; Pepper M
    Cell Rep; 2016 Dec; 17(12):3193-3205. PubMed ID: 28009289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recognition of Plasmodium falciparum mature gametocyte-infected erythrocytes by antibodies of semi-immune adults and malaria-exposed children from Gabon.
    Gebru T; Ajua A; Theisen M; Esen M; Ngoa UA; Issifou S; Adegnika AA; Kremsner PG; Mordmüller B; Held J
    Malar J; 2017 Apr; 16(1):176. PubMed ID: 28446190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Research note: HLA degenerate T-cell epitopes from Plasmodium falciparum liver stage-specific antigen 1 (LSA-1) are highly conserved in isolates from geographically distinct areas.
    Ravichandran M; Doolan DL; Cox-Singh J; Hoffman SL; Singh B
    Parasite Immunol; 2000 Sep; 22(9):469-73. PubMed ID: 10972854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the immune response of a new malaria vaccine based on the modification of cryptic epitopes.
    Shen Y; Wang J; Huang Y; Liang J; Liu X; Wu D; Jiang H; Zhao Y; Li Y
    Parasitol Res; 2016 May; 115(5):1907-13. PubMed ID: 26833322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.
    Polley SD; Conway DJ; Cavanagh DR; McBride JS; Lowe BS; Williams TN; Mwangi TW; Marsh K
    Vaccine; 2006 May; 24(19):4233-46. PubMed ID: 16111789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy model for antibody-mediated pre-erythrocytic malaria vaccines.
    White MT; Griffin JT; Riley EM; Drakeley CJ; Moorman AM; Sumba PO; Kazura JW; Ghani AC; John CC
    Proc Biol Sci; 2011 May; 278(1710):1298-305. PubMed ID: 20943696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development.
    Aguiar JC; Bolton J; Wanga J; Sacci JB; Iriko H; Mazeika JK; Han ET; Limbach K; Patterson NB; Sedegah M; Cruz AM; Tsuboi T; Hoffman SL; Carucci D; Hollingdale MR; Villasante ED; Richie TL
    PLoS One; 2015; 10(8):e0136109. PubMed ID: 26292257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional Antibodies and Protection against Blood-stage Malaria.
    Teo A; Feng G; Brown GV; Beeson JG; Rogerson SJ
    Trends Parasitol; 2016 Nov; 32(11):887-898. PubMed ID: 27546781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malaria vaccines and human immune responses.
    Long CA; Zavala F
    Curr Opin Microbiol; 2016 Aug; 32():96-102. PubMed ID: 27262417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigens for pre-erythrocytic malaria vaccines: building on success.
    Speake C; Duffy PE
    Parasite Immunol; 2009 Sep; 31(9):539-46. PubMed ID: 19691557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmodium falciparum serine repeat antigen 5 (SE36) as a malaria vaccine candidate.
    Palacpac NM; Arisue N; Tougan T; Ishii KJ; Horii T
    Vaccine; 2011 Aug; 29(35):5837-45. PubMed ID: 21718740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of the Plasmodium falciparum asexual blood-stage synthetic peptide vaccine SPf66.
    Millet P; Campbell GH; Sulzer AJ; Grady KK; Pohl J; Aikawa M; Collins WE
    Am J Trop Med Hyg; 1993 Mar; 48(3):424-31. PubMed ID: 7682382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.